New Guidance for High-Risk Groups The U.S. Food and Drug Administration (FDA) amended its emergency use authorizations on Tuesday, granting individuals aged 65 and older and those with compromised immune systems access to an additional dose of the bivalent COVID-19 vaccine. This regulatory shift allows these high-risk groups to receive a second booster shot immediately,…
FDA Updates Vaccine Guidance The U.S. Food and Drug Administration (FDA) announced on Tuesday that it has amended the emergency use authorizations for Pfizer-BioNTech and Moderna bivalent COVID-19 vaccines. This regulatory shift permits individuals aged 65 and older, as well as those with compromised immune systems, to receive an additional booster dose to bolster their…
New Guidance for High-Risk Groups The U.S. Food and Drug Administration (FDA) announced on Tuesday an amendment to the emergency use authorizations for Pfizer-BioNTech and Moderna bivalent COVID-19 vaccines. This regulatory shift permits adults aged 65 and older, as well as specific immunocompromised individuals, to receive an additional dose of the updated booster, providing an…
